Nebivolol in the treatment of chronic heart failure.

Vasc Health Risk Manag · 2007 · PMC2291309 · PMID 18078016

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Both carvedilol and nebivolol showed a trend towards an increased exercise capacity at 6 months and there was no reported decline in exercise capacity with nebivolol at earlier assessments.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.